Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark H Wilcox
Leeds Teaching Hospitals NHS Trust
Study Chair - Philip Stanley
Bradford Teaching Hospitals NHS Foundation Trust
Principal Investigator - Tim Planche
St George's Healthcare NHS Trust
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St George'S University Hospitals Nhs Foundation Trust
Tooting, London, United Kingdom
- Bradford Teaching Hospitals Nhs Foundation Trust
Bradford, West Yorkshire, United Kingdom
- Leeds Teaching Hospitals Nhs Trust
Leeds, West Yorkshire, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2015
- Primary completion
- 31 Dec 2016
- Completion
- 31 Dec 2017
- Last update posted
- 9 Sept 2021
- Registered enrollment
- 203
- Registry id
- NCT02461901
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.